# Cariprazine: Comparison of Slow- and Immediate-release Forms

> **NCT02165098** · PHASE1 · COMPLETED · sponsor: **Gedeon Richter Plc.** · enrollment: 160 (actual)

## Conditions studied

- Pharmacokinetic Profile

## Interventions

- **DRUG:** Cariprazine prolonged release tablet A
- **DRUG:** Cariprazine prolonged release tablet B
- **DRUG:** Cariprazine capsule
- **DRUG:** Cariprazine PR tablet A
- **DRUG:** Cariprazine PR tablet B

## Key facts

- **NCT ID:** NCT02165098
- **Lead sponsor:** Gedeon Richter Plc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2016-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02165098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02165098, "Cariprazine: Comparison of Slow- and Immediate-release Forms". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02165098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*